| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Dorin-Bogdan Borza | Q40709048 |
| P2093 | author name string | Dorin-Bogdan Borza | |
| P2860 | cites work | A Temporal Model of Human IgE and IgG Antibody Function | Q21131207 |
| The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation | Q81009325 | ||
| Urinary heparanase activity in patients with Type 1 and Type 2 diabetes | Q83082153 | ||
| IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression | Q85913681 | ||
| Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 | ||
| Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement | Q24619612 | ||
| M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy | Q24652978 | ||
| Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review | Q26782025 | ||
| Structural basis for sialic acid-mediated self-recognition by complement factor H | Q27696183 | ||
| Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement | Q28141398 | ||
| The human complement factor H: functional roles, genetic variations and disease associations | Q28263548 | ||
| A new map of glycosaminoglycan and C3b binding sites on factor H | Q28289935 | ||
| Heparanase in glomerular diseases | Q28303555 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome | Q33347509 | ||
| Attachment of the soluble complement regulator factor H to cell and tissue surfaces: relevance for pathology | Q33358401 | ||
| Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome | Q33364092 | ||
| Mechanisms of immune-deposit formation and the mediation of immune renal injury | Q33368686 | ||
| Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions | Q33369509 | ||
| Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome | Q33375219 | ||
| Factor H family proteins and human diseases | Q33380214 | ||
| Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions | Q33405609 | ||
| Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. | Q33530824 | ||
| Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H | Q33596128 | ||
| Glomerular disease: looking beyond pathology | Q33715776 | ||
| Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease | Q33764140 | ||
| Membranous nephropathy: from models to man | Q33872569 | ||
| Experimental membranous nephropathy redux | Q34248969 | ||
| Rituximab therapy in idiopathic membranous nephropathy: a 2-year study | Q34362660 | ||
| IgG subclasses and allotypes: from structure to effector functions | Q34368678 | ||
| Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice | Q34537391 | ||
| Early-childhood membranous nephropathy due to cationic bovine serum albumin | Q34660515 | ||
| Complement in kidney disease: core curriculum 2015. | Q34747321 | ||
| Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy | Q34783516 | ||
| The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice | Q34813568 | ||
| The role of properdin in the assembly of the alternative pathway C3 convertases of complement | Q46814862 | ||
| Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis | Q47298666 | ||
| Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies | Q47891468 | ||
| Membranous nephropathy in a patient with hereditary complete complement C4 deficiency | Q47924846 | ||
| Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. | Q51038554 | ||
| Factors influencing susceptibility of LEW rats to heymann nephritis | Q52212072 | ||
| Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. | Q55061113 | ||
| Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange | Q55178105 | ||
| A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice | Q61415573 | ||
| Inhibition of complement activation by IgG4 antibodies | Q61601640 | ||
| Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies | Q61849373 | ||
| Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies | Q61849375 | ||
| Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy | Q67547023 | ||
| Demonstration of C3d deposits in membranous nephropathy | Q70370081 | ||
| Distribution of IgG subclasses in membranous nephropathy | Q70380725 | ||
| The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy | Q70467772 | ||
| Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases | Q70580293 | ||
| Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis | Q71682513 | ||
| Identification of complement regulatory domains in human factor H | Q71700078 | ||
| Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein | Q71803052 | ||
| No complement receptor 1 stumps on podocytes in human glomerulopathies | Q73338477 | ||
| Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis | Q78124929 | ||
| Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces | Q79287502 | ||
| Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy | Q80497195 | ||
| A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis | Q80907742 | ||
| Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy | Q35142743 | ||
| Hyperlipidemia and thrombotic complications in patients with membranous nephropathy | Q35201542 | ||
| Murine membranous nephropathy: immunization with α3(IV) collagen fragment induces subepithelial immune complexes and FcγR-independent nephrotic syndrome. | Q35851046 | ||
| The role of complement in inflammatory diseases from behind the scenes into the spotlight | Q35963146 | ||
| Contrasting roles of complement activation and its regulation in membranous nephropathy | Q36084446 | ||
| Cellular response to injury in membranous nephropathy | Q36084457 | ||
| Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization | Q36084460 | ||
| Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. | Q36199508 | ||
| Treatment of idiopathic membranous nephropathy | Q36280345 | ||
| Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy | Q36280364 | ||
| Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis | Q36401571 | ||
| Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor | Q36426142 | ||
| Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration. | Q36804333 | ||
| Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials | Q36810470 | ||
| A new role for complement in experimental membranous nephropathy in rats | Q37026755 | ||
| The C-terminus of complement factor H is essential for host cell protection | Q37238656 | ||
| Rituximab therapy for membranous nephropathy: a systematic review | Q37412829 | ||
| A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury | Q37434667 | ||
| The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey | Q37727594 | ||
| Neonatal Fc receptor promotes immune complex-mediated glomerular disease | Q37733571 | ||
| CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation | Q38080868 | ||
| Properdin in complement activation and tissue injury | Q38118454 | ||
| The role of complement in membranous nephropathy | Q38155652 | ||
| The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H? | Q38171012 | ||
| Glomerular deposition of mannose-binding lectin in human glomerulonephritis | Q38324829 | ||
| Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy | Q39476063 | ||
| Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice | Q40607655 | ||
| Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy | Q40865063 | ||
| Pathogenesis of glomerular damage in glomerulonephritis | Q40866501 | ||
| Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy | Q40922243 | ||
| Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats | Q41866765 | ||
| Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis | Q41885401 | ||
| IgG subclasses and complement pathway in segmental and global membranous nephropathy. | Q43164390 | ||
| Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly | Q44441855 | ||
| Effect of nephritogenic antibody on complement regulation in cultured rat glomerular epithelial cells | Q44939623 | ||
| The Heymann nephritis antigenic complex: megalin (gp330) and RAP. | Q46239590 | ||
| Idiopathic membranous nephropathy: diagnosis and treatment | Q46781970 | ||
| Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies | Q46789719 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 157 | |
| P577 | publication date | 2016-04-25 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy | |
| P478 | volume | 7 |
| Q50327901 | A New Classification System for IgG4 Autoantibodies |
| Q90424188 | Advances of the experimental models of idiopathic membranous nephropathy (Review) |
| Q55459963 | Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. |
| Q39200048 | Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology. |
| Q90398431 | Expression levels of complement regulatory proteins (CD35, CD55 and CD59) on peripheral blood cells of patients with chronic kidney disease |
| Q38949784 | Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation |
| Q38959093 | Membranous nephropathy in the kidney allograft |
| Q37699835 | Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy |
| Q49947954 | The role of the alternative pathway of complement activation in glomerular diseases |
Search more.